PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
- First Posted Date
- 2007-11-14
- Last Posted Date
- 2015-10-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 70
- Registration Number
- NCT00557856
- Locations
- 🇺🇸
Medical University of South Carolina, Hollings Cancer Center, Charleston, South Carolina, United States
🇮🇹S.C Diagnostica Radiologica 2, Milano, Italy
🇮🇹S.C. Chirurgia Generale Indirizzo Oncologico 1 (epato-gastro-pancreatica), Milano, Italy
A Study Of PF-03732010 In Patients With Advanced Solid Tumors
- Conditions
- Neoplasms
- Interventions
- Drug: PF-03732010
- First Posted Date
- 2007-11-14
- Last Posted Date
- 2012-03-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 43
- Registration Number
- NCT00557505
- Locations
- 🇰🇷
Pfizer Investigational Site, Seoul, Korea, Republic of
A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents
- First Posted Date
- 2007-11-12
- Last Posted Date
- 2016-05-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 26
- Registration Number
- NCT00556998
- Locations
- 🇺🇸
Pfizer Investigational Site, Houston, Texas, United States
Study Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant Patients
- First Posted Date
- 2007-11-09
- Last Posted Date
- 2008-05-30
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00556257
Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer
- Conditions
- Stomach Neoplasms
- Interventions
- First Posted Date
- 2007-11-09
- Last Posted Date
- 2011-12-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 34
- Registration Number
- NCT00555672
- Locations
- 🇪🇸
Pfizer Investigational Site, Madrid, Spain
An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma.
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2007-11-09
- Last Posted Date
- 2015-03-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 53
- Registration Number
- NCT00555906
- Locations
- 🇺🇸
University of Kansas Cancer Center and Medical Pavilion, Westwood, Kansas, United States
🇺🇸Barnes-Jewish Hospital, St. Louis, Missouri, United States
🇺🇸Medical University of South Carolina, Charleston, South Carolina, United States
Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer
- Conditions
- Stomach Neoplasms
- Interventions
- First Posted Date
- 2007-11-08
- Last Posted Date
- 2013-01-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 76
- Registration Number
- NCT00555620
- Locations
- 🇰🇷
Pfizer Investigational Site, Seoul, Korea, Republic of
Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury
- Conditions
- Brain InjuriesGrowth Hormone Deficiency
- Interventions
- Drug: Placebo
- First Posted Date
- 2007-11-07
- Last Posted Date
- 2010-06-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 10
- Registration Number
- NCT00555009
- Locations
- 🇬🇧
Pfizer Investigational Site, Salford, Manchester, United Kingdom
Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer
- First Posted Date
- 2007-11-04
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 55
- Registration Number
- NCT00553254
- Locations
- 🇰🇷
Seoul National University Hospital, Department of Internal Medicine, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Department of Medicine, Seoul, Korea, Republic of
🇰🇷Severance Hospital, Yonsei University College of Medicine, Yonsei Cancer Center, Seoul, Korea, Republic of
Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer
- First Posted Date
- 2007-11-04
- Last Posted Date
- 2015-03-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 27
- Registration Number
- NCT00553696
- Locations
- 🇯🇵
Saku Central Hospital, GI Devision, Saku, Nagano, Japan
🇯🇵Aichi cancer center central hospital / Medical Oncology, Nagoya, Aichi, Japan
🇯🇵Shizuoka Cancer Center, Suntougun, Shizuoka, Japan